Turn Therapeutics (TTRX)
Develops GX-03 for skin disease while licensing medical-device products.
$9.82
At close−0.00 (−0.05%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions20 holders · as of Mar 31, 2026 | 1.55% | 462.3K shares | |
| Otherremainder | 98.45% | 29.33M shares |
29.79M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Institutions13F, as of Mar 31, 2026
20 holders · 462.3K shares · 3 new positions · 6 increased · 2 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| DDFG, Inc | 70.5K | 0.24% | +18.2K | Apr 22, 2026 |
| Millennium Management LLC | 69.8K | 0.23% | −25.9K | May 15, 2026 |
| Wellington Shields & Co., LLC | 65.7K | 0.22% | 0 | May 4, 2026 |
| Vanguard Capital Management LLC | 49.5K | 0.17% | +49.5Knew | May 15, 2026 |
| Tamar Securities, LLC | 30.0K | 0.10% | +15.0K | May 14, 2026 |
| Brown Brothers Harriman & Co | 23.7K | 0.08% | 0 | May 14, 2026 |
| XTX Topco Ltd | 19.7K | 0.07% | −5.4K | May 15, 2026 |
| Hightower Advisors, LLC | 19.7K | 0.07% | 0 | May 5, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.